Discovery Medicine CVU CEDD, GlaxoSmithKline, Department of Discovery Medicine, 709 Swedeland Rd, UW2301, King of Prussia, PA 19406, USA.
Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):459-66. doi: 10.1161/ATVBAHA.111.238493. Epub 2011 Nov 17.
We investigated the impact of lipoprotein lipase (LPL) gene mutations on apolipoprotein B (apoB)-100 metabolism.
We studied 3 subjects with familial LPL deficiency; 14 subjects heterozygous for the LPL gene mutations Gly188Glu, Trp64Stop, and Ile194Thr; and 10 control subjects. Very-low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), and low-density lipoprotein (LDL)-apoB-100 kinetics were determined in the fed state using stable isotope methods and compartmental modeling. Compared with controls, familial LPL deficiency had markedly elevated plasma triglycerides and lower VLDL-apoB-100 fractional catabolic rate (FCR), IDL-apoB-100 FCR, VLDL-to-IDL conversion, and VLDL-apoB-100 production rate (P<0.01). Compared with controls, Gly188Glu had higher plasma triglyceride and VLDL- and IDL-apoB-100 concentrations and lower VLDL- and IDL-apoB-100 FCR (P<0.05). Plasma triglycerides were not different, but IDL-apoB-100 concentration and production rate and VLDL-to-IDL conversion were lower in Trp64Stop compared with controls (P<0.05). No differences between controls and Ile194Thr were observed.
Our results confirm that hypertriglyceridemia is a key feature of familial LPL deficiency. This is due to impaired VLDL- and IDL-apoB-100 catabolism and VLDL-to-IDL conversion. Single-allele mutations of the LPL gene result in modest to elevated plasma triglycerides. The changes in plasma triglycerides and apoB-100 kinetics are attributable to the effects of the LPL genotype.
研究脂蛋白脂肪酶(LPL)基因突变对载脂蛋白 B(apoB)-100 代谢的影响。
我们研究了 3 例家族性 LPL 缺乏症患者;14 例 LPL 基因突变 Gly188Glu、Trp64Stop 和 Ile194Thr 杂合子患者;以及 10 例对照者。采用稳定同位素法和房室模型,在进食状态下测定了极低密度脂蛋白(VLDL)、中间密度脂蛋白(IDL)和低密度脂蛋白(LDL)-apoB-100 动力学。与对照组相比,家族性 LPL 缺乏症患者的血浆甘油三酯显著升高,VLDL-apoB-100 分解代谢率(FCR)、IDL-apoB-100 FCR、VLDL 向 IDL 转化率和 VLDL-apoB-100 生成率均降低(P<0.01)。与对照组相比,Gly188Glu 患者的血浆甘油三酯和 VLDL 和 IDL-apoB-100 浓度更高,VLDL 和 IDL-apoB-100 FCR 更低(P<0.05)。与对照组相比,Trp64Stop 患者的血浆甘油三酯水平无差异,但 IDL-apoB-100 浓度和生成率以及 VLDL 向 IDL 转化率较低(P<0.05)。在 Ile194Thr 患者与对照组之间未观察到差异。
我们的研究结果证实,高甘油三酯血症是家族性 LPL 缺乏症的一个关键特征。这是由于 VLDL 和 IDL-apoB-100 代谢和 VLDL 向 IDL 转化率受损所致。LPL 基因突变的单等位基因突变导致血浆甘油三酯适度至升高。血浆甘油三酯和 apoB-100 动力学的变化归因于 LPL 基因型的影响。